Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...
CMAJ21h
Orthostatic hypotension in a patient with HIV: uncovering adrenal insufficiency from fluticasone–cobicistat interactions
KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...
Palatin Completes Patient Enrollment In Phase 2 Study Of PL8177 In Ulcerative Colitis, Shares Up 16%
Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...
Joplin Globe19h
Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting
Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego. “These ...
Le Lézard20h
Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies
Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, today announced it has successfully raised an aggregate $11 million as an initial Series A ...
Irish Independent on MSN7h
Patients with severe asthma suffer ‘delayed diagnosis and restricted access to drugs’, report says
A young teacher who suffers from severe asthma has spoken of how patients with the high-risk condition can be left on ...
imt.ie57m
You might be interested in…Osteoporosis
Affected children and young adults should undergo a thorough diagnostic workup, including collection of clinical history, ...
gastroenterologyadvisor16h
Low Anti-TNF Levels Linked to Treatment Failure in Children With CD
Low anti-TNF levels during infliximab or adalimumab maintenance treatment are linked to increased risk for treatment failure in pediatric CD.
Daily18h
Early detection, intensive treatment critical for high-risk patients with Kawasaki Disease, reveals research
Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...
Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
Commercial, Clinical and Regulatory Expertise Establish Clearside as the Leader in Suprachoroidal Delivery -- Multiple Events at Asia-Pacific ...
Managed Healthcare Executive20h
CVS Caremark Makes Changes in Diabetes Coverage for 2025
CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...
Great Pet Care on MSN15h
Cat Wheezing: What It Sounds Like and Why It Happens
And as astute pet parents, we usually have a good idea of what these sounds mean: feed me, pet me, please let me in. But would you recognize the sound of a cat wheezing? If the answer is no, don’t ...